Study identifier:NIS-OJP-ARI-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Retrospective survey of bone fracture in post-menopausal breast cancer patients with Arimidex 1 mg as adjuvant therapy
Breast Cancer
-
No
-
Female
2205
Observational
N/A
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|